Handling anticancer drugs: from hazard identification to risk management? - PubMed (original) (raw)
Handling anticancer drugs: from hazard identification to risk management?
Marja Sorsa et al. Ann N Y Acad Sci. 2006 Sep.
Abstract
The potential health hazards involved with antineoplastic agents have been known for decades. Many anticancer drugs are recognized as carcinogens and genotoxins in experimental assays. Second cancers have been recorded in follow-up studies with treated patients. The first findings on occupational exposures among hospital personnel administering chemotherapy were reported only in 1979. Since that time a magnitude of studies have been published using various chemical and biological exposure measurements. These findings prompted improvements in the handling practices of personnel working with anticancer drugs. In spite of strict guidelines for the safe handling of cancer chemotherapeutic agents and extensive improvements in the handling facilities in hospitals, also recent studies have revealed detectable, even if generally much decreased, amounts of indicator drugs in air and surface wipe samples, also including biological samples of personnel in hospital pharmacies and cancer therapy wards. Follow-up measurements show that application of strict safety precautions in hospitals decreases the biological exposure and/or effect markers to the level of unexposed referents. Open information and constant tutoring of personnel to avoid the hazards when working with anticancer drugs is absolutely necessary with the increasing use of these important drugs.
Similar articles
- Exposure of hospital pharmacists and nurses to antineoplastic agents.
McDevitt JJ, Lees PS, McDiarmid MA. McDevitt JJ, et al. J Occup Med. 1993 Jan;35(1):57-60. J Occup Med. 1993. PMID: 8423505 - Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs.
Rekhadevi PV, Sailaja N, Chandrasekhar M, Mahboob M, Rahman MF, Grover P. Rekhadevi PV, et al. Mutagenesis. 2007 Nov;22(6):395-401. doi: 10.1093/mutage/gem032. Epub 2007 Sep 13. Mutagenesis. 2007. PMID: 17855733 - Hazardous anticancer drugs in health care: environmental exposure assessment.
Connor TH. Connor TH. Ann N Y Acad Sci. 2006 Sep;1076:615-23. doi: 10.1196/annals.1371.021. Ann N Y Acad Sci. 2006. PMID: 17119238 - Monitoring of occupational exposure to cytostatic anticancer agents.
Sorsa M, Anderson D. Sorsa M, et al. Mutat Res. 1996 Aug 17;355(1-2):253-61. doi: 10.1016/0027-5107(96)00031-0. Mutat Res. 1996. PMID: 8781586 Review. - Biomarkers of occupational exposure do anticancer agents: a minireview.
Suspiro A, Prista J. Suspiro A, et al. Toxicol Lett. 2011 Nov 10;207(1):42-52. doi: 10.1016/j.toxlet.2011.08.022. Epub 2011 Sep 3. Toxicol Lett. 2011. PMID: 21911042 Review.
Cited by
- Occupational Exposure to Antineoplastic Drugs: Identification of Job Categories Potentially Exposed throughout the Hospital Medication System.
Hon CY, Teschke K, Chua P, Venners S, Nakashima L. Hon CY, et al. Saf Health Work. 2011 Sep;2(3):273-81. doi: 10.5491/SHAW.2011.2.3.273. Epub 2011 Sep 30. Saf Health Work. 2011. PMID: 22953211 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical